Share our website:
European Patients Academy
  Choose your language:  

EUPATI Schweiz / Suisse / Svizzera association

EUPATI CH

Our aims

The aims of EUPATI CH are to act as the central point for inquiries and cooperation platform for patient empowerment and involvement in medicines R&D processes in Switzerland.

1. Contributing to patient empowerment for active involvement in medicines research and development (R&D).

2. Supporting public awareness raising for the EUPATI education material.

3. Fostering partnerships with medicines R&D stakeholders in Switzerland to promote public involvement in all aspects of medicines R&D.

 

Donation
EUPATI CH is a nonprofit organisation. In order to fullfill our aims and retain our independence, we need financial support.

EUPATI CH acknowledges any funds and grants. Please do not hesitate to contact us.

E-mail: secretariat@ch.eupati.eu

Swiss postfinance account:
IBAN: CH84 0900 0000 8956 5298 4
BIC: POFICHBEXXX

Statutes

 

The EUPATI CH statutes are available here
in english
in german
in french
in italian

Annex 1 (Code of Conduct) and Annex 2 (Advisory Board) available in english.

Bodies of EUPATI CH

  1. The General Assembly of EUPATI CH,
  2. The Executive Board,
  3. The Auditors,
  4. The Advisory Board.

A request to become an Advisory Board member of EUPATI CH shall be sent to the Executive Board by sending an email to the secretariat indicating the intent and commitment to support the platform.

Membership

Please send your completed application form for membership to the Executive Board, via its secretariat. By applying for membership (in writing or verbally) you automatically agree with our statutes.

The Executive Board will inform you on its decision on your membership application.

Categories of membership
EUPATI CH has the following membership categories:

  • Ordinary members: individual persons,
  • Ordinary members: institution representatives

Application form
You can download the application form here

Membership fees
Free for 2017, the fees will be determined by the General Assembly in October 2017.

Newsletter

Newsletter EUPATI CH Issue 02 (11.09.2017)
in english
in german
in french
in italian

Newsletter EUPATI CH Issue 01 (26.05.2017)
in english
in german
in french
in italian

Strategy and Workplan

Strategy and workplan of the EUPATI CH association 2017 - 2020 is available
in english

Publications and Articles

EUPATI CH articles, statements, interviews and citations.
Pharmafakten Mai 2016
Pharmajournal April 2017
Lymphoma Info Mai 2017

We are proud to be member of EUPATI CH

Members

Patient representatives and organisations
Positivrat Schweiz
Swiss Forum Lung Cancer
Lymphoma Schweiz
Endo-Help
Krebsliga
Krebsforschung Schweiz
Kinderkrebs Schweiz
FMF & AID Global Association
Schweizerische Morbus Crohn / Colitis ulcerosa Vereinigung (SMCC )

Academic representatives and organisations
University Hospital Basel (USB)
Ente Ospedaliero Cantonale (EOC)
Swiss Clinical Trial Organisation (SCTO)
Gesundheitsbildung Schweiz
Schweizerische Arbeitsgemeinschaft für Klinsche Krebsforschung ( SAKK)

Pharmaceutical Industry and for-profit organisations
open

Individual members
Matthew May
Dr. Brigitte Franke-Bray
Stéphane Charbon
Emilie Berger
Prof. Uyen Huynh-Do
Julia Amann
Thomas Lanzewizki

Advisory Board

Our Advisory Board (AB) shall provide non-binding expert advice and guidance and support EUPATI CH strategically, read more about your roles here.

Membership of the Advisory Board (AB) is open to all patients, patient advocates, patient organisations, consumer organisations, academics, institutions, university hospitals, healthcare associations, industry representatives, companies, government agencies representatives, regulatory authorities, medical journalists and anyone interested.

Members of our Advisory Board
Florian Klett, EUPATI Fellow
Cordula Landgraf, Swissmedic
Daniela Gunz, healthbank innovation AG
Stephanie Ludwig, Takeda Pharma AG